SANTIAGO EWIG, ANTONI TORRES, MUSTAFA EL-EBIARY, NEUS FÀBREGAS, CARMEN HERNÁNDEZ, JULIÀ GONZÁLEZ, JOSE MARIA NICOLÁS, and LUIS SOTO

Size: px
Start display at page:

Download "SANTIAGO EWIG, ANTONI TORRES, MUSTAFA EL-EBIARY, NEUS FÀBREGAS, CARMEN HERNÁNDEZ, JULIÀ GONZÁLEZ, JOSE MARIA NICOLÁS, and LUIS SOTO"

Transcription

1 Bacterial Colonization Patterns in Mechanically Ventilated Patients with Traumatic and Medical Head Injury Incidence, Risk Factors, and Association with Ventilator-associated Pneumonia SANTIAGO EWIG, ANTONI TORRES, MUSTAFA EL-EBIARY, NEUS FÀBREGAS, CARMEN HERNÁNDEZ, JULIÀ GONZÁLEZ, JOSE MARIA NICOLÁS, and LUIS SOTO Servei de Pneumologia i Al lergia Respiratoria, Servei de Anestesia, Servei de Microbiologia, Area de Vigilancia Intensiva, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain We prospectively evaluated the relation of upper airway, lower airway, and gastric colonization patterns with the development of pneumonia and its etiology in 48 patients with surgical (n 25) and medical (n 23) head injury. Initial colonization was assessed by cultures of nasal and pharyngeal swabs, tracheobronchial aspirates, gastric juice, and bronchoscopically retrieved protected specimen brush. Follow-up colonization was determined until the end points extubation, suspected ventilatorassociated pneumonia (VAP), or death. The initial colonization rate at any site at ICU admission was 39/47 (83%). It mainly accounted for Group I pathogens (Streptococcus pneumoniae, Staphylococcus aureus, Hemophilus influenzae) of the upper and lower airways. At follow-up, colonization rates with Group II pathogens (Gram-negative enteric bacilli and Pseudomonas spp.) increased significantly. The high initial bacterial load with Group I pathogens of the upper airways and trachea decreased during Days 2 to 4, whereas that of Group II pathogens increased. Upper airway colonization was an independent predictor of follow-up tracheobronchial colonization (odds ratio [OR], 9.9; 95% confidence interval [CI], 1.8 to 56.3 for initial colonization with Group I pathogens; OR, 23.9; 95% CI, 3.8 to for follow-up colonization with Group II pathogens). Previous (short-term) antibiotics had a protective effect against colonization with Group I pathogens of the lower respiratory tract (OR, 0.2; 95% CI, 0.05 to 0.86), but they were a risk factor for colonization with Group II pathogens (OR, 6.1; 95% CI, 1.3 to 29). Initial tracheobronchial colonization with Group I pathogens was associated with a higher probability of early onset pneumonia (OR, 4.1; 95% CI, 0.7 to 23.3), whereas prolonged antibiotic treatment ( 24 h) independently predicted late-onset pneumonia (OR, 9.2; 95% CI, 1.7 to 51.3). We conclude that patients with head injury are colonized in the airways mainly by Group I pathogens early in the evolution of illness. The upper airways represent the main reservoir for subsequent lower airway colonization with Group I pathogens. Previous (short-term) antibiotic treatment is protective against initial tracheobronchial colonization with Group I pathogens, but it represents a risk factor for subsequent lower airway colonization by Group II pathogens. Ewig S, Torres A, El- Ebiary M, Fàbregas N, Hernández C, González J, Nicolás JM, Soto L. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury: incidence, risk factors, and association with ventilator-associated pneumonia. AM J RESPIR CRIT CARE MED 1999;159: (Received in original form March 24, 1998 and in revised form September 4, 1998) Supported by Commisionat per a Universitats i Recerca de la Generalitat de Catalunya, 1997 SGR 00086, Fundació Clínic/CIRIT, IDIBAPS Hospital Clínic Barcelona, and Instituto de cooperacion iberoamericana (ICI) Dr. Santiago Ewig was a 1997 Research Fellow at the Medizinische Universitätsklinik and Poliklinik Bonn, Bonn, Germany. Dr. Luis Soto was a 1993 Research Fellow at the Hospital de Enfermedades de Tórax, Santiago de Chile, Chile. Correspondence and requests for reprints should be addressed to Dr. Antoni Torres, Hospital Clínic i Provincial, Servei de Pneumologia i Al lergia Respiratoria, Villaroel 170, Barcelona, Spain. atorres@medicina.ub.es Am J Respir Crit Care Med Vol 159. pp , 1999 Internet address: Patients with traumatic and medical head injury have been shown to be at particularly high risk of ventilator-associated pneumonia (VAP). Its incidence is estimated to reach 40 to 50% (1 7). The most frequent etiologic agents found include Staphylococcus aureus and, less frequently, Steptococcus pneumoniae and Hemophilus influenzae (4, 5, 8, 9). The early onset of pulmonary infection and the peculiar microbial pattern may be due to oropharyngeal or gastric colonization followed by high inoculum aspiration of oropharyngeal secretions. Patients may aspirate oropharyngeal secretions shortly after brain injury, during resuscitation, and as a consequence of intubation. Although the predominant pathogens of early onset pneumo-

2 Ewig, Torres, El-Ebiary, et al.: Head Injury and Ventilator-associated Pneumonia 189 nia in patients with head injury have been well established in several epidemiologic studies, the precise relation of prior upper airway, tracheobronchial, and gastric colonization patterns with the development of pneumonia and microbial patterns has not been settled. Moreover, the relative homogeneity of a population with a high incidence of early onset pneumonia that in turn is equally at risk for late onset pneumonia gives the opportunity to study the differences and similarities in the pathogenesis of early- and late-onset pneumonia. Thus, the aims of the study were to describe the qualitative and quantitative colonization patterns in patients with surgical and medical head injury, to search for risk factors of initial and follow-up bacterial colonization at different sites of the upper and lower airways as well as the stomach, and finally to determine the incidence and microbial etiology of VAP and its relation to prior colonization patterns. METHODS Patient Population We prospectively studied 48 patients admitted at two different medical and surgical ICUs at a 1,000-bed teaching hospital during a 16-mo period. Patients were enrolled because of head trauma or medical stroke. All patients were orally intubated from the beginning of the study. No patient had tracheostomy. The time lapse between intubation and the beginning of the study protocol was 24 h in all cases. Selective digestive decontamination (SDD) was not administered in any case. Subglottic drainage was not applied to any patient. Exclusion criteria were severe immunosuppression (organ transplantation, neutropenia /L, AIDS) and evidence of pulmonary infection or suspicion of gross aspiration at admission. The study was approved by the local Ethical Committee. Informed consent was obtained from the nearest relatives of every patient. Data Collection Demographic, clinical, and treatment data were collected from all patients. These included: age, sex, type of cerebral injury, comorbid illnesses, McCabe s prognostic score, antimicrobial therapy, simplified acute physiologic score (SAPS), Glasgow Coma Score, Pa O2 /FI O2 at admission, the initial presence of shock, prophylaxis and treatment of cerebral edema, presence of intracranial pressure monitoring, type of stress ulcer prophylaxis, type of nutrition, days of mechanical ventilation, and outcome. Study Protocol Within the first 24 h after admission to the ICU and intubation, nasal and pharyngeal swabs (NS and PS) (Medio Amies, Barcelona, Spain), tracheobronchial aspirate (Mocstrap; Productes Clinics S.A., La Llagosta, Barcelona, Spain) as well as 3 ml of gastric juice were obtained. Next, flexible bronchoscopy was performed with protected specimen brush (PSB) sampling from either lower lobe. NS, PS, TBAS, and GJ samples were taken daily until the fourth day of ICU admission, and every 72 h thereafter, until the end points extubation, development of suspected VAP, or death. In case of death, necropsy was done when possible. Chest radiographs were taken daily. Patients with suspected pneumonia were investigated by TBAS and flexible bronchoscopy with PSB in the area most prominently affected. In addition, blood cultures were obtained. The preparation of all samples was performed as described previously (10). All samples were quantitatively plated on blood, chocolate, Wilkins-Chalgren, and Sabouraud agar media (serial dilutions of 1:10, 1:100, and 1:1,000). If negative, the plates were discarded after 3 d of testing for aerobic bacteria and after 4 wk of testing for fungi. If positive, counts of colony-forming units (cfu) per milliliter and identification as well as susceptibility testing using standard methods were done for the microorganisms (11). Bacterial (and fungal) indices were calculated using a formula previously described (12). Definitions Microorganisms. Microorganisms were classified into potentially pathogenic microorganisms (PPMs) and non-ppms. PPMs were those recognized as causing respiratory infections: Gram-positive cocci such as Streptococcus pneumoniae and Staphylococcus aureus, Gram-negative cocci such as Moraxella catarrhalis, and Gram-negative rods such as Hemophilus influenzae, Enterobacteriaceae and Pseudomonas aeruginosa. Non-PPMs were those microorganisms usually not involved in respiratory infections in the nonimmunosuppressed host (Streptococcus viridans group, coagulase-negative staphylococci, Neisseria spp., Corynebacterium spp., and Candida spp.) (13). Colonization. The presence of bacterial microorganisms in the upper airways (as determined in NS or PS) or the stomach (as determined in GJ) in at least one sample in any amount was considered as colonization. In addition, the presence of bacterial microorganisms in the tracheobronchial tree (as determined by TBAS) and lower airways (as determined in PSB) in at least one sample in any amount was considered as colonization in the absence of confirmed pneumonia (11). PPMs and non-ppms were analyzed separately. For purpose of analysis, Gram-positive isolates (Streptococcus pneumoniae and methicillin-sensitive Staphylococcus aureus [MSSA]) and Hemophilus influenzae were grouped together (Group I pathogens) and opposed to the group of Gram-negative aerobic bacilli (GNEB), Pseudomonas aeruginosa, and Acinetobacter spp. (Group II pathogens). Pneumonia. Pneumonia was clinically suspected upon the presence of new and/or progressive pulmonary infiltrates on chest radiograph in addition to two of the following criteria: fever 38.3 C or hypothermia 36 C, leukocytosis /L, and purulent tracheobronchial secretions. Pneumonia was considered as definite in the presence of (1) a colony count 10 3 cfu/ml of one or more PPMs from cultures of PSB or 10 5 cfu/ml from cultures of TBAS; (2) a PPM in blood culture in the absence of an extrapulmonary focus; (3) a response to antimicrobial therapy in the absence of an alternative diagnosis; or (4) histologic evidence of pneumonia (consolidated foci and polymorphonuclear leukocyte accumulation in bronchioles and adjacent alveoli) in necropsy. PPMs (but not non-ppms) recovered above the defined cutoffs for the confirmation of pneumonia were considered as causative microorganisms. Non-PPMs were analyzed separately. Early-onset pneumonia was diagnosed when pneumonia developed within the first 4 d of mechanical ventilation, and late-onset pneumonia when developing after the fourth day of mechanical ventilation. Brain lesions. Brain lesions were diagnosed when head trauma (open or closed, needing surgery or not) or medical stroke were present. A Glasglow coma score 9 was defined as coma (14). Antibiotic treatment. Previous (short-term) antibiotic treatment was defined as the in-hospital administration of any dose of any antibiotics prior to the first sampling of respiratory and gastric secretions. Prolonged antibiotic treatment was defined as the in-hospital administration of antibiotics for more than 24 h. Treatment with barbiturates. Treatment with barbiturates was defined as inravenous perfusion of sodium thiopental in a dose 1 mg/ kg/h for controlling intracranial hypertension. Statistical Analysis Results are expressed as mean SD if not indicated otherwise. Student s t test for independent and paired continuous variables and the chi-square test or Fisher s exact test were used when appropriate to compare proportions. In order to detect risk factors for colonization, the following factors were tested for an association with initial and follow-up colonization rates with Group I and Group II pathogens: SAPS ( 15 or 15, according to the mean value of the whole population), Glasgow Coma Score ( 9 or 9, according to the definition of coma), as well as treatment with barbiturates (yes/no), previous (short-term) antibiotic treatment (yes/no) (for initial and follow-up colonization), prolonged antibiotic treatment (for follow-up colonization), enteral nutrition, stress ulcer prophylaxis with H 2 -blockers, and intracranial pressure monitoring. Moreover, the importance of upper airways and stomach for follow-up tracheobronchial colonization was also assessed by multivariate stepwise forward logistic regression models including followup tracheobronchial colonization as an independent variable and initial and follow-up upper airway and gastric colonization as covariates.

3 190 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL Initial and follow-up colonization rates as well as enteral nutrition, treatment with H 2 -blockers, previous (short-term) antibiotic treatment, prolonged antibiotic treatment, and duration of mechanical ventilation were tested for an association with early- and late-onset pneumonia. Variables significantly associated with pneumonia were included in a multivariate stepwise forward logistic regression. Time-to-event tables for early-onset pneumonia were calculated according to the Kaplan-Meier method, with log-rank test for significance of differences. All p values are two-sided, and the level of significance was set at 5%. RESULTS Patients Forty-eight patients (28 men, 20 women) were included in the study. Mean age was yr. Brain lesions included: medical causes, 23 (48%) (spontaneous cerebral hemorrhage, n 9 and stroke, n 14); surgical causes, 25 (52%) (head trauma: cerebral concussion or contusion, n 7; cerebral edema, n 2; hemorrhage, n 16, including 12 patients with polytrauma). Coma was present in 40 patients (20 surgical, 20 medical). The main features of the study population are listed in Table 1. The mean number of microbiologic investigations performed in each patient was 4 2 (range, 1 to 6). Antibiotic Treatment Previous (short-term) antibiotic treatment in 22 patients (44%) consisted of intravenously administered monotherapy with second (n 8) and third (n 4) generation cephalosporins and clindamycin (n 1) as well as combination regimens with third generation cephalosporins, aminoglycosides, and clindamycin (n 2), second generation cephalosporins or penicillin, or clindamycin and aminoglycosides (n 1 each), third generation cephalosporins and clindamycin (n 1), first generation cephalosporin, penicillin, and aminoglycoside (n 1), and third generation cephalosporins, penicillin, and vancomycin (n 1), and others (2). Prolonged antibiotic treatment was given in 18 patients (38%) for a mean of 5 3 d and included monotherapy with quinolones (n 1), third generation cephalosporins (n 6) as well as combination regimen with third generation cephalosporins and aminoglycosides (n 5), clindamycin (n 1), aminoglycosides and clindamycin (n 3), and clindamycin and aminoglycosides (n 1), penicillin and vancomycin (n 1). Initial Colonization The incidence of initial colonization with PPMs in at least one sample was 39/47 (83%). Colonization rates in the upper airways (NS or PS: 26/46, 57%) and tracheobronchial tree (TBAS: 23/41, 56%, and PSB: 21/36, 58%) were similar. The stomach was colonized in 16/36 (44%) of patients. The total and local colonization rates were not significantly different when comparing medical with surgical patients. Initial colonization in NS, PS, TBAS, and PSB frequently accounted for Group I pathogens (NS or PS: 20/46, 44%; TBAS: 20/41, 49%; PSB: 15/36, 42%). In contrast, GJ showed these pathogens in only 4/36 (11%) cases (NS/PS, TBAS, PSB versus GJ, p for all comparisons). The reverse trend was found for Group II pathogens (NS or PS: 9/46, 16%; TBAS: 4/41, 10%; PSB: 7/36, 19%) and GJ: 14/36, 39% (NS/ PS, TBAS, PSB versus GJ, p 0.05, p 0.005, p 0.07, respectively) (Figure 1). There were no significant differences between medical and surgical patients. The frequencies of bacterial isolates are listed in Table 2. Follow-up Colonization Follow-up cultures were performed in 43 patients. Of these, 39 (91%) had colonization with PPMs in at least one sample. The colonization rates at the upper airways and TBAS increased significantly as compared with the initial investigation (NS or PS: 37/43, 86%, p 0.01; TBAS: 33/43, 77%, p 0.04), with a similar trend for GJ (25/42, 60%, p 0.18). Colonization rates were not significantly different when comparing medical with surgical patients. The colonization rates for Group I pathogens were similar in the upper airways (NS or PS: 24/43, 56%; TBAS: 19/43, 44%) and GJ: 3/42, 7% as compared with the initial cultures. The Group I colonization rates of NS/PS and TBAS continued to be significantly different as compared with GJ (p for both comparisons). However, the rates of Group II pathogens were significantly higher in the upper airways (NS or PS: 25/43, 58%, p 0.001; TBAS: 21/43, 49%, p ; and in GJ: 25/42, 60%, p 0.01) (Figure 1). The colonization rates of NS/PS and TBAS were no longer different as compared with GJ (p 0.89 and 0.32, respectively). Thus, the increase in colonization rates during follow-up was mainly due to an increase of colonization with Group II pathogens. This trend was uniformly observed in medical and surgical patients. The frequencies of bacterial isolates are listed in Table 2. Parameter TABLE 1 CHARACTERISTICS AT ICU ADMISSION OF 48 PATIENTS WITH BRAIN INJURY Medical (n 23) Surgical (n 25) All (n 48) Age, yr* Comorbidity At least one More than one Comorbid illnesses Cardiac Pulmonary 2 2 Arterial hypertension Psychiatric (depression) Epilepsy 1 1 Alcoholism 1 1 Others McCabe Score Nonfatal Ultimately fatal Rapidly fatal SAPS Glasgow Coma Score Pa O2 /FI O Initial presence of shock, yes/no 6/17 3/22 9/39 Treatment with barbiturates, yes/no 6/17 4/21 10/38 Stress ulcer prophylaxis Sucralfat H 2 -blockers None Nutrition Enteral Parenteral Intracranial pressure monitoring, yes/no 11/12 15/10 23/25 Hours of mechanical ventilation Antibiotic treatment None Previous (short-term) Prolonged * p p Simplified Acute Physiological Score. Medical: hepatopathy (liver cirrhosis), prior cerebrovascular disease, hypothyroidism. Surgical: chronic arterial occlusive disease, chronic nephropathy (dialysis), HIV infection.

4 Ewig, Torres, El-Ebiary, et al.: Head Injury and Ventilator-associated Pneumonia 191 Time Course of Follow-up Colonization In patients with negative initial and positive follow-up cultures, the mean time to colonization was h (n 7) for Group I pathogens and h (n 19) for Group II pathogens in the upper airways (NS or PS), (n 5) and h (n 15) in the tracheobronchial tree and 24 (n 1) and h (n 12) in GJ, respectively. Similarly, in patients with positive initial cultures with Group I pathogens but absence of Group II pathogens, the mean time to follow-up colonization with Group II pathogens was h in the upper airways (NS or PS) (n 9), h in the tracheobronchial tree (n 4), and 24 0 h in GJ (n 2). initial Group I bacterial load (log 10 Bacterial Index) of the nose and trachea was significantly higher as compared with the initial Group II load ( versus , p and versus , p , respectively), with a similar trend for the pharynx ( versus , p 0.1). After deflection points (between Days 2 and 4), Group II bacterial loads turned out to be significantly higher in the nose (0 versus ), pharynx (0 versus ), and trachea ( versus ) on Day 6 (p 0.01, each). Conversely, there was a significantly higher initial Group II bacterial load in gastric juice ( versus , p 0.01), whereas the Group I bacterial load dropped to zero by Day 4 (Figure 2). Quantitative Colonization Patterns The mean bacterial indices of both Groups I and II pathogens in nose, pharynx, and trachea showed a similar evolution. The Risk Factors for Bacterial Colonization Glasgow Coma Score 9 was associated with an initial upper airway colonization (NS or PS) with Group I pathogens. Previous (short-term) antibiotic treatment was protective for an initial colonization of the tracheobronchial tree and the lower respiratory tract (PSB) with Group I pathogens. Conversely, previous (short-term) antibiotic treatment was a risk factor for colonization of the tracheobronchial tree and the lower respiratory tract with Group II pathogens (Table 3). A Glasgow Coma Score 9 and previous (short-term) antibiotic treatment were associated with follow-up colonization with Group I pathogens of the upper airways. Treatment with barbiturates and previous (short-term) antibiotic treatment were associated with follow-up tracheobronchial colonization with Group I pathogens (Table 3). TABLE 2 FREQUENCY OF SINGLE BACTERIAL ISOLATES IN THE INITIAL AND FOLLOW-UP INVESTIGATION BY NASAL SWABS (NS), PHARYNGEAL SWABS (PS), TRACHEOBRONCHIAL ASPIRATES, PROTECTED SPECIMEN BRUSH (PSB), AND GASTRIC JUICE Initial Investigation NS or PS (n 46) TBAS (n 41) PSB (n 36) GJ (n 36) Pathogen Staphylococcus aureus* Streptococcus pneumoniae Hemophilus influenzae GNEB (non-pseudomonas spp.) Pseudomonas aeruginosa Polymicrobial (more than one PPM) Non-PPMs (without or with PPMs) Sterile Follow-up Investigation NS or PS (n 43) TBAS (n 43) GJ (n 42) Figure 1. Comparison of initial and follow-up colonization rates with Group I and Group II pathogens at different sites. NS nasal swab; PS pharyngeal swab; TBAS tracheobronchial aspirate; PSB protected specimen brush; GJ gastric juice. Solid bars initial colonization rate in %; dotted bars follow-up colonization rate in %. Group I pathogens: p NS for all comparisons. (See METH- ODS for definitions of Group I and II pathogens.) Pathogen Staphylococcus aureus* Streptococcus pneumoniae Hemophilus influenzae GNEB (non-pseudomonas spp.) Pseudomonas aeruginosa Polymicrobial (more than one PPM) Non-PPMs (without or with PPMs) Sterile Definition of abbreviations: GNEB gram-negative enteric bacilli; PPM potentially pathogenic microorganisms. * All isolates were methicillin-susceptible (MSSA). No isolate of Acinetobacter spp. was observed.

5 192 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL Figure 2. Quantitative colonization patterns in the nose, pharynx, trachea, and stomach. Log 10 BI mean sum of logarithms of colony counts, i.e., mean bacterial index (BI). Data are presented as mean SEM. Note that Days 5 and 6 of sampling correspond to Days 7 and 10 of mechanical ventilation. Number of samples on days of sampling, 1 to 6; nose: 43, 40, 33, 23, 17, 5; pharnyx: 44, 40, 31, 25, 17, 4; trachea: 41, 37, 28, 23, 17, 6; stomach: 36, 40, 30, 25, 14, 5. Dotted lines Group I pathogens; solid lines Group II pathogens. (See METHODS for definitions of Group I and II pathogens.) TABLE 3 ANALYSIS OF RISK FACTORS FOR INITIAL AND FOLLOW-UP BACTERIAL COLONIZATION IN PATIENTS WITH SURGICAL AND MEDICAL HEAD INJURY Parameter OR 95% CI p Value Initial colonization of upper airways (NS or PS) with Group I pathogens Glasgow Coma Score 9 Undefined Undefined 0.01 Initial tracheobronchial colonization with Group I pathogens Previous (short-term) antibiotic treatment Initial colonization of lower airways (PSB) with Group I pathogens Previous (short-term) antibiotic treatment Initial tracheobronchial colonization with Group II pathogens Previous (short-term) antibiotic treatment Undefined Undefined 0.01 Initial colonization of lower airways (PSB) with Group II pathogens Previous (short-term) antibiotic treatment Follow-up colonization of upper airways (NS or PS) with Group I pathogens Glasgow Coma Score Previous (short-term) antibiotic treatment Follow-up tracheobronchial colonization with Group I pathogens Treatment with barbiturates Previous (short-term) antibiotic treatment Definition of abbreviations: CI confidence interval; NS nasal swab; OR odds ratio; PS pharyngeal swab; PSB protected specimen brush; TBAS tracheobronchial aspirate.

6 Ewig, Torres, El-Ebiary, et al.: Head Injury and Ventilator-associated Pneumonia 193 Figure 3. Comparison of initial and follow-up colonization rates with non-ppms and Candida spp. at different sites. NS nasal swab; PS pharyngeal swab; TBAS tracheobronchial aspirate; PSB protected specimen brush; GJ gastric juice. Solid bars initial colonization rate in %; dotted bars follow-up colonization rate in %; p NS for all comparisons. Sequence of Colonization Eleven of 24 patients (46%) with initial Group I colonization of the upper airways had follow-up tracheobronchial colonization with the same microorganism (including seven with concurrent initial tracheobronchial and two with gastric colonization). By the same token, six of the nine patients (67%) with initial Group II colonization of the upper airways had followup tracheobronchial colonization with the same microorganism (including three with concurrent initial tracheobronchial and five with gastric colonization). Conversely, three of four patients (75%) initially colonized in the stomach with Group I pathogens had concurrent tracheobronchial colonization with the same microorganism. Six of 14 patients (43%) with initial Group II colonization of the stomach developed follow-up tracheobronchial colonization with the same microorganism. Of these, five had concurrent initial upper airway and two had tracheobronchial colonization with the same microorganism. The inclusion of initial and follow-up upper airway and gastric colonization with Group I pathogens in a multivariate model revealed that initial upper airway colonization with Group I pathogens was an independent predictor of follow-up tracheobronchial colonization with Group I pathogens (odds ratio [OR], 9.9; 95% confidence interval [CI], 1.8 to 56.3; p 0.01). Similarly, in a second multivariate model including initial and follow-up airway and gastric colonization with Group II pathogens, follow-up upper airway colonization with Group II pathogens was predictive for follow-up tracheobronchial colonization with these pathogens (OR, 23.9; 95% CI, 3.8 to 153.3; p 0.001). Non-PPMs and Candida spp. The initial colonization rates with non-ppms were highest in the upper airways (NS/PS: 44/46; 96%), followed by TBAS (28/41, 68%) and GJ (22/36, 61%), and lowest in PSB (16/36, 44%). At follow-up, rates were virtually unchanged (NS/PS: Figure 4. Quantitative colonization patterns in the nose, pharynx, trachea, and stomach. Log 10 BI mean sum of logarithms of colony counts, i.e., mean bacterial index (BI). Log 10 FI mean sum of logarithms of colony counts, i.e., mean fungal index (FI). Data are presented as mean SEM. Number of samples on sampling Days 1 to 6; see Figure 2. Dotted lines non potentially pathogenic microorganisms (non PPMs); solid lines Candida spp.

7 194 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL one further patient. The presence of pneumonia was additionally confirmed at necropsy in one patient and by clinical response in seven patients. Thus, the incidence of confirmed pneumonia was 19/48 (40%). The mean duration of mechanical ventilation prior to the development of pneumonia was 5 2 d. Early-onset pneumonia accounted for nine episodes (47%) (three medical, six surgical), and late-onset pneumonia for a further 10 episodes (53%) (six medical, four surgical). Prolonged antimicrobial pretreatment was present in 10 (53%) patients. Risk Factors of Pneumonia There was a trend for initial tracheobronchial colonization with Group I pathogens to predict early-onset pneumonia (OR, 4.1; 95% CI, 0.7 to 23.3; p 0.09). Moreover, time-toevent analysis (Kaplan-Meier) revealed a significant association of initial tracheobronchial colonization with Group I pathogens with the probability to develop early-onset pneumonia (p 0.02). No such association could be detected for the initial upper airway colonization with Group I pathogens (Figure 5). Follow-up tracheobronchial colonization with Group II pathogens (OR, 5.4; 95% CI, 1.0 to 29.6; p 0.03), duration of mechanical ventilation (OR, 7.7; 95% CI, 1.4 to 41.6; p 0.01) and prolonged antibiotic treatment (OR, 11.1; 95% CI, 2.0 to 61.9; p 0.01) were predictors of late-onset pneumonia. A trend was also shown for initial tracheobronchial colonization with Group II pathogens (OR, 8.3; 95% CI, 0.9 to 75.8; p 0.09). A multivariate analysis, including the three variables significantly associated with late-onset pneumonia, revealed that only prolonged antibiotic treatment was predictive of late-onset pneumonia (OR, 9.2; 95% CI, 1.7 to 51.3; p 0.01). Conversely, no association of non-ppms and Candida spp. was found with early- or late-onset pneumonia, respectively. Figure 5. Kaplan-Meier plots for the probability to develop earlyonset pneumonia in the presence of colonization with Group I pathogens in the upper airways and in the trachea. Solid lines patients not colonized with Group I pathogens; dotted lines patients colonized with Group I pathogens. 41/43, 95%, p 1.0; TBAS: 32/43, 74%, p 0.53; GJ: 24/42, 57%, p 0.72). With regard to Candida spp., initial colonization rates were very low in the upper airways (NS/PS: 4/46, 9%), TBAS (1/41, 2%), and PSB (1/36, 3%), but reached 25% (9/36) in GJ. At follow-up, all rates increased, but differences did not reach significance (NS/PS: 7/43, 16%, p 0.28; TBAS: 6/43, 14%, p 0.1; GJ: 17/42, 41%, p 0.15) (Figure 3). Quantitative colonization patterns showed highest bacterial loads of non-ppms in the pharynx (mean bacterial index, ) and the highest load of Candida spp. in the stomach (mean bacterial index, ). During Days 1 to 6, only the bacterial load of non-ppms of the pharynx decreased significantly ( versus , p 0.02) (Figure 4). No predictor for colonization with non-ppms or Candida spp. could be identified. Incidence of Pneumonia Pneumonia was clinically suspected in 21 (44%) patients (nine medical, 12 surgical), and microbiologically confirmed by PSB and/or TBAS in 10/21 (48%) patients and by blood cultures in Etiology of Pneumonia The etiologic agents of early-onset pneumonia were most commonly Group I pathogens (four of five, 80%), whereas Group II pathogens were predominant in late-onset pneumonia (five of six, 83%). Four pneumonia episodes had polymicrobial etiology (two early-onset and two late-onset pneumonia episodes). All causative pathogens of pneumonia together with initial and follow-up colonization are shown in Table 4. Six of eight PPMs (75%) involved in early-onset pneumonia were already present in the upper airways, TBAS or PSB at the initial investigation and all eight (100%) during follow-up. Conversely, only two of eight PPMs (25%) involved in late-onset pneumonia were initially present, whereas seven of eight (88%) emerged during follow-up. With regard to non-ppms and Candida spp., the sequence of colonization and pneumonia was less evident. In earlyonset pneumonia, non-ppms in significant amounts (Streptococcus viridans) were present in only two of nine (22%) patients. These patients had previously been colonized at the upper airways (both) and in the tracheobronchial tree (one) with the same pathogen. In late-onset pneumonia, non-ppms in significant amounts were present in four of ten (40%) patients (Streptococcus milleri, Streptococcus viridans [2], and Corynebacterium spp.). Of these, the latter three had been previously colonized with the same pathogen (all three in the upper airways, one each in the tracheobronchial tree and the stomach). Outcome Patients developing early-onset pneumonia had a comparable duration of mechanical ventilation ( versus h, p 0.44) and length of ICU stay (11 7 versus 9 7 d, p

8 Ewig, Torres, El-Ebiary, et al.: Head Injury and Ventilator-associated Pneumonia 195 TABLE 4 ETIOLOGY OF MICROBIOLOGICALLY CONFIRMED VENTILATOR-ASSOCIATED PNEUMONIA IN ELEVEN CASES AND ITS RELATION TO PRIOR COLONIZATION IDNR (M/S) (D) A Initial Colonization Follow-up Colonization Pneumonia Early onset 1 (2) * 2 (M) (3) 3 (3) 4 (3) 5 (M) (4) Late onset 6 (5) 7 (M) (5) 8 (M) (5) 9 (7) ** 10 (M) (8) 11 (10) E. coli (NS, PS, TBAS, PSB, GJ) H. influenzae (NS, PS, TBAS, PSB, GJ) (NS, PS, TBAS, PSB) H. influenzae (NS, PS) S. pneumoniae S. pneumoniae E. coli (PS, TBAS, GJ) /GNEB (NS, PS) /H. influenzae /GNEB / (NS, PS) /H. influenzae (PS) S. pneumoniae (PS) (NS, PS) /S. pneumoniae/h. influenzae /E. cloacae (PS) E. cloacae E. cloacae (PS, TBAS, PSB, GJ) K. pneumoniae /E. cloacae (NS, PS, TBAS) E. cloacae (NS, PS, TBAS) K. pneumoniae E. coli (PSB not done) /H. influenzae (PSB) (TBAS not done) S. pneumoniae (Blood culture) TBAS Aspergillus fumigatis PSB negative /S. pneumoniae/h. influenzae /S. pneumoniae (PSB) /E. cloacae /E. cloacae E. cloacae (PSB) E. coli (PS, TBAS, GJ) (PSB) / (NS, PS) /Enterobacter spp./ Definition of abbreviations: A history of antibiotic treatment; D days; GJ gastric juice; IDNR identification number; M/S medical or surgical; NS nasal swab; PS pharyngeal swab; PSB protected specimen brush; TBAS tracheobronchial aspirate. * Cefuroxim (short-term). Norfloxacin (short-term). None. Clindamycin/cefotaxim/netilmicin (prolonged). Cefuroxim (prolonged). Cefotaxime (prolonged). ** Penicillin/cefazolin/netilmicin (prolonged). Clindamycin/netilmicin (prolonged). Ceftazidime/amikacin (prolonged).

9 196 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL ) as compared with those without. Results were similar when only survivors were included (duration of mechanical ventilation, versus h, p 0.31; and length of ICU stay, 13 7 versus 10 6 d, p 0.46). Conversely, patients developing late-onset pneumonia had a significantly longer mean duration of mechanical ventilation ( versus h, p 0.01) and longer ICU stay (14 6 versus 8 6 d, p 0.02) as compared with those without. When only survivors were included, differences in duration of mechanical ventilation remained significant ( versus h, p 0.01), whereas there remained only a corresponding nonsignificant trend for a longer ICU stay in patients with pneumonia (13 5 versus 10 7 d, p 0.15). Sixteen patients died (32%). There was no significant difference in mortality rates between patients with and without pneumonia (6/16, 38% versus 13/32, 41%; p 0.83). Accordingly, mortality in the presence of early- and late-onset pneumonia was similar (3/9, 33% versus 3/10, 30%; p 0.88). Pneumonia was the cause of death in only one patient with late-onset pneumonia. DISCUSSION The main findings of the present study are the following. (1) Initial colonization rate in our study was very high (39/47, 83%). (2) Initial bacterial load with Group I pathogens in the upper airways and trachea was higher than bacterial load with Group II pathogens. A deflection point was observed (between Days 2 and 4) where the opposite occurred. The stomach was mainly colonized with Group II pathogens, with a slight increase of bacterial load during follow-up. (3) Previous (short-term) antibiotic treatment had a protective effect against initial and follow-up tracheobronchial and initial lower respiratory tract colonization with Group I pathogens. However, it was a risk factor for initial tracheobronchial and lower respiratory tract colonization with Group II pathogens. (4) Upper airway colonization independently predicted subsequent tracheobronchial colonization with the same group of pathogens. (5) Initial tracheobronchial colonization with Group I pathogens was associated with an increased probability of early-onset pneumonia, whereas prolonged antibiotic treatment independently predicted late-onset pneumonia. Airway bacterial colonization is regarded as a common event in critically ill patients 2 or 3 d after the onset of mechanical ventilation (15), with airway colonization being directly related to the aspiration of pharyngeal and/or gastric contents (16). In our population, we found that upper and lower airway and/or gastric colonization was already initially present in 83% of patients as assessed by sampling within 24 h after intubation. This observation suggests that patients with head injury experience a compromise of local airway immune defense mechanisms very early during their illness, which allows microorganisms to adhere and persist at mucosal surfaces. Impaired levels of consciousness would additionally favor continuous aspiration and the subsequent development of pneumonia (17). This view is further supported by the fact that early colonization was found to be mainly due to community endogenous pathogens. Accordingly, it has been argued that tracheobronchial colonization with Staphylococcus aureus (18, 19) and Hemophilus influenzae (20) may result from direct inoculation during emergency intubation or endotracheal tube manipulation. In fact, in our study initial colonization of upper and lower airways mainly accounted for Group I pathogens, whereas Group II pathogens were only infrequently isolated. The reverse was true for gastric colonization. These colonization patterns were not different in surgical as compared with medical patients, indicating that head injury has similar consequences for local host defenses regardless of a history of trauma. The increase in colonization rates at all sites during follow-up was mainly due to colonization with Group II pathogens and developed within 48 h. This pattern of colonization accounts for the traditionally described events after initiation of mechanical ventilation. The quantitative view on the evolution of colonization revealed two corresponding main colonization patterns. The first pattern demonstrable in the upper airways and the trachea showed a higher initial bacterial load with Group I pathogens, which steadily decreased during Days 3 to 6 of sampling; conversely, the bacterial load with Group II pathogens increased rapidly after Day 4, and at Day 6 of sampling always was significantly higher than the bacterial load with Group I pathogens. A second different pattern was evident in the stomach, which had a high initial and slightly increasing bacterial load with Group II pathogens but only a marginal initial and rapidly decreasing load with Group I pathogens. Two conditions obviously accounted for an important part of these dynamics: the presence of coma as well as of previous (short-term) and prolonged antibiotic treatment. A Glasgow Coma Score 9 was associated with initial upper airway colonization with Group I pathogens, and a Glasgow Coma Score 9 as well as treatment with barbiturates represented risk factors for follow-up colonization with these pathogens of the upper airways and the tracheobronchial tree, respectively. Treatment with barbiturates has also been shown by others to be dose-dependently associated with a higher incidence of colonization of the respiratory tract and pneumonia with Grampositive bacteria in mechanically ventilated patients with cerebral edema (21). Although pentobarbitone is known to inhibit mucociliary clearance in sheep (22), also evidence for adverse effects of thiopentone on cellular (23) and humoral (24) immunological functions has been found. On the other hand, previous (short-term) antibiotic treatment was protective against an initial and follow-up tracheobronchial and initial lower airway colonization with Group I pathogens, whereas it represented a risk factor for initial colonization with Group II pathogens. Moreover, prolonged antibiotic treatment was an independent risk factor for late-onset pneumonia, which on the other hand was mainly due to Group II pathogens. The qualitative and quantitative colonization patterns exposed so far support the concept of early- and late-onset pneumonia as entities with different pathogeneses and etiologies. From our data it is evident that the upper and lower airways are the main reservoir for early-onset pneumonia caused by Group I pathogens, which in turn account for the majority of early-onset pneumonia episodes. The sequence of initial Group I colonization of the upper airways with concomitant and/or subsequent tracheobronchial colonization with the same microorganism was demonstrable in 46% of patients with initial Group I colonization of the upper airways, and initial upper airway colonization with Group I pathogens was predictive for tracheobronchial follow-up colonization with these pathogens. Accordingly, antibiotic treatment covering Group I pathogens does protect against the colonization of the tracheobronchial tree with these pathogens. In line with these findings, we previously could show that short-term intravenous administration of high-dose cefuroxime (3 g in two repeated doses) has a protective effect against the development of early-onset pneumonia in patients with structural coma (5). However, beyond the fourth day of mechanical ventilation, colonization of all sites essentially accounted for Group II pathogens, and prolonged antibiotic treatment became potentially harmful. Both the upper airways as well as the stomach could be shown to initially

10 Ewig, Torres, El-Ebiary, et al.: Head Injury and Ventilator-associated Pneumonia 197 harbor Group II pathogens concomitantly and/or subsequently identified in the tracheobronchial tree. These observations corroborate previous findings from our group, suggesting that both the upper airways as well as the stomach may represent an independent reservoir for late-onset pneumonia (10). However, we found that follow-up airway colonization with Group II pathogens was strongly associated with followup tracheobronchial colonization with these pathogens, suggesting the superior importance of the upper airway reservoir for late-onset tracheobronchial colonization and pneumonia. Other studies have suggested similar conclusions (25 31). However, the majority of our population was not ventilated for more than 1 wk, and thus these results must be interpreted with caution (32). In our study, no independent risk factor for early-onset pneumonia could be determined. However, the probability of early-onset pneumonia was significantly increased in the presence of initial tracheobronchial colonization with Group I pathogens. We found that follow-up colonization of the tracheobronchial tree with Group II pathogens, the duration of mechanical ventilation, and prolonged antibiotic treatment were predictors of late-onset pneumonia, with the latter representing the only independent predictor. Corresponding findings have been reported in a previous study (33) and from other investigators (34, 35). With regard to non-ppms, colonization rates and quantitative colonization patterns did not follow those observed in PPMs. Likewise, the sequence of colonization and pneumonia was less evident for non-ppms and Candida spp. The presence of these microorganisms did not predict early- or late-onset pneumonia, and given the very high initial and follow-up colonization rates of the upper airways, non-ppms were only rarely found in pneumonia. There was also no evident association of non-ppms to early- or late-onset pneumonia. These observations support the concept of excluding non-ppms from the exposed pathogenetic framework of early- and late-onset pneumonia. In conclusion, our study confirms the high incidence of VAP in patients with head injury. Patterns of colonization and pneumonia suggest that these patients suffer from an alteration of airway immune defense very early during their illness. The upper airways represent the most important reservoir of subsequent tracheobronchial colonization with Group I pathogens, which in turn is associated with early-onset pneumonia. Both the upper airways and the stomach may be independent reservoirs for tracheobronchial colonization with Group II pathogens and late-onset pneumonia. Preventive measures to reduce the incidence of early-onset pneumonia in this population may aim at an eradication of both upper and lower airway colonizers. In order to limit the adverse effect of a predisposition to colonization and pneumonia with Group II pathogens, the intravenous administration of antibiotics in future prophylaxis trials should be confined to less than 24 h. References 1. Langer, M., M. Cigada, M. Mandelli, P. Mosconi, G. Tognoni, and ICUGIC Early onset pneumonia: a multicenter study in intensive care units. Intensive Care Med. 13: Rodriguez, J. L., K. J. Gibbons, L. G. Bitzer, R. E. Dechert, S. M. Steinberg, and L. M. Flint Pneumonia: incidence, risk factors and outcome in injured patients. J. Trauma 31: Hsieh, A. H., M. J. Bishop, P. S. Kubilis, D. W. Nellwell, and D. J. Pierson Pneumonia following closed head injury. Am. Rev. Respir. Dis. 146: Rello, J., V. Ausina, M. Ricart, C. Puzo, A. Net, and G. Prats Nosocomial pneumonia in critically ill comatose patients: need for a differential therapeutic approach. Eur. Respir. J. 5: Sirvent, J. M., A. Torres, M. El-Ebiary, P. Castro, J. de Battle, and A. Bonet Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am. J. Respir. Crit. Care Med. 155: Romig, D. A., D. W. Voth, C. Liu, and C. E. Brackett Bacterial flora and infection in patients with brain injury. J. Neurosurg. 38: Goodpasture, H. C., D. A. Romig, D. W. Voth, C. Liu, and C. E. Brackett A prospective study of tracheobronchial bacterial flora in acutely brain-injured patients with and without antibiotic prophylaxis. J. Neurosurg. 47: Espersen, F., and J. Gabrielsen Pneumonia due to Staphylococcus aureus during mechanical ventilation. J. Infect. Dis. 144: Rello, J., E. Quintana, V. Ausina, C. Puzo, A. Net, and G. Prats Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am. Rev. Respir. Dis. 142: Torres, A., M. El-Ebiary, J. Gonzalez, M. Ferrer, J. Puig de la Bellacasa, A. Gene, A. Martos, and R. Rodriguez-Roisin Gastric and pharyngeal flora in nosocomial pneumonia acquired during mechanical ventilation. Am. Rev. Respir. Dis. 148: Lennette, E. H., A. Bullows, W. J. Hausler, and H. J. Sadhomy Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington, DC. 12. Johanson, W. G., J. J. Seidenfeld, P. Gomez, R. de los Santos, and J. J. Coalson Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am. Rev. Respir. Dis. 137: Cabello, H., A. Torres, R. Celis, M. El-Ebiary, J. Puig de la Bellacasa, A. Xaubet, J. Gonzalez, C. Agusti, and N. Soler Distal airway bacterial colonisation in healthy subjects and chronic lung diseases: a bronchoscopic study. Eur. Respir. J. 10: Rimel, R. W., and G. W. Tyson The neurologic examination in patients with central nervous system trauma. J. Neurosci. Nurs. 12: Johanson, W. G., A. K. Pierce, J. P. Sandford, and J. D. Thomas Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N. Engl. J. Med. 281: Johanson, W. G., A. K. Pierce, J. P. Sanford, and J. D. Thomas Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann. Intern. Med. 77: Rello, J., V. Ausina, J. Castella, A. Net, and G. Prats Nosocomial respiratory tract infections in multiple trauma patients: influence of level of consciousness with implications for therapy. Chest 102: Korinek, A. M., M. J. Laisne, M. H. Nicolas, L. Raskine, V. Deroin, and M. J. Sanson-Lepors Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit. Care Med. 21: Baker, A. M., J. W. Meredith, and E. F. Haponik Pneumonia in intubated trauma patients: microbiology and outcomes. Am. J. Respir. Crit. Care Med. 153: Nair, P., K. Jani, and P. J. Sanderson Transfer of oropharyngeal bacteria into the trachea during endotracheal intubation. J. Hosp. Infect. 8: Eberhardt, K. E., B. M. Thimm, A. Spring, and W. R. Maskos Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study. Infection 20: Landa, J. F., J. A. Hirsch, and M. I. Labeaux Effects of topical and general anesthetic agents on tracheal mucous velocity of sheep. J. Appl. Physiol. 38: Neuwelt, E. A., K. Kikuchi, S. A. Hill, P. Lipsky, and E. Frenkel Barbiturate inhibition of lymphocyte function. J. Neurosurg. 56: Salo, M Effects of thiopentone on immunoglobulin production in vitro. Br. J. Anesthesiol. 63: Niederman, M. S., R. Mantovani, P. Schoch, J. Papas, and A. M. Fein Patterns and routes of tracheobronchial colonization in mechanically ventilated patients: the role of nutritional status in colonization of lower airway by Pseudomonas species. Chest 95: Reusser, P., W. Zimmerli, D. Scheidegger, G. A. Marbet, M. Buser, and K. Gyr Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J. Infect. Dis. 160: Simms, H. H., E. DeMaria, L. McDonald, D. Peterson, A. Robinson, and K. W. Burchard Role of gastric colonization in the develop-

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement

CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,

More information

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000

More information

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia JORDI RELLO, MIGUEL GALLEGO, DOLORS MARISCAL, ROSARIO SOÑORA, and JORDI VALLES Intensive Care, Respiratory and Microbiology

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health

More information

Healthcare-associated infections acquired in intensive care units

Healthcare-associated infections acquired in intensive care units SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit

More information

Pradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD; Julie Hughes, RGN; and Rick van Saene, MD

Pradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD; Julie Hughes, RGN; and Rick van Saene, MD Topical Antibiotics on Tracheostoma Prevents Exogenous Colonization and Infection of Lower Airways in Children* Pradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD;

More information

PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION.

PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION. Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP)

More information

Original articles. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies

Original articles. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies Thorax 1999;54:867 873 867 Original articles Serveis de Pneumologia I Al.lèrgia Respiratòria Anestesia, Microbiologia, Anatomia Patologica, Hospital Clínic, Departament de Medicina, Universitat de Barcelona,

More information

Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial

Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial Mitra BDrakulovic, Antoni Torres, Torsten T Bauer, Jose M Nicolas, Santiago Nogué,

More information

Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study

Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study Eur Respir J 1997; 10: 1137 1144 DOI: 10.1183/09031936.97.10051137 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Bacterial colonization

More information

ANWICU knowledge

ANWICU knowledge ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted

More information

Hospital Acquired Pneumonias

Hospital Acquired Pneumonias Hospital Acquired Pneumonias Hospital Acquired Pneumonia ( HAP ) Hospital acquired pneumonia ( HAP ) is defined as an infection of the lung parenchyma developing during hospitalization and not present

More information

Routine endotracheal cultures for the prediction of sepsis in ventilated babies

Routine endotracheal cultures for the prediction of sepsis in ventilated babies Archives of Disease in Childhood, 1989, 64, 34-38 Routine endotracheal cultures for the prediction of sepsis in ventilated babies T A SLAGLE, E M BIFANO, J W WOLF, AND S J GROSS Department of Pediatrics,

More information

Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology

Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology Severe Community-acquired Pneumonia Risk Factors and Follow-up Epidemiology MAURICIO RUIZ, SANTIAGO EWIG, ANTONI TORRES, FRANCISCO ARANCIBIA, FRANCESC MARCO, JOSEP MENSA, MIGUEL SANCHEZ, and JOSE ANTONIO

More information

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION

HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical

More information

Online Supplement for:

Online Supplement for: Online Supplement for: INFLUENCE OF COMBINED INTRAVENOUS AND TOPICAL ANTIBIOTIC PROPHYLAXIS ON THE INCIDENCE OF INFECTIONS, ORGAN DYSFUNCTIONS, AND MORTALITY IN CRITICALLY ILL SURGICAL PATIENTS A PROSPECTIVE,

More information

B. Barreiro*, J. Dorca*, L. Esteban*, E. Prats*, J.M. Escribá**, R. Verdaguer +, F. Gudiol ++, F. Manresa*

B. Barreiro*, J. Dorca*, L. Esteban*, E. Prats*, J.M. Escribá**, R. Verdaguer +, F. Gudiol ++, F. Manresa* Eur Respir J, 1995, 8, 1543 1547 DOI: 10.1183/09031936.95.08091543 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Risk factors for the development

More information

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions

More information

Critical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma

Critical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma - is an acute infection of the pulmonary parenchyma - is a common infection encountered by critical care nurses when it complicates the course of a serious illness or leads to acute respiratory distress.

More information

VAP Prevention bundles

VAP Prevention bundles VAP Prevention bundles Dr. Shafiq A.Alimad MD Head of medical department at USTH YICID workshop, 15-12-2014 Care Bundles What are they & why use them? What are Care Bundles? Types of Care Bundles available

More information

The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation

The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation Eur Respir J 1999; 13: 546±551 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 The presence and sequence of endotracheal tube colonization

More information

Hospital-acquired Pneumonia

Hospital-acquired Pneumonia Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired

More information

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong

More information

Research & Reviews of Pneumonia

Research & Reviews of Pneumonia Chapter 1 Pathophysiology of Hospital Acquired Pneumonia Priyam Batra * ; Purva Mathur 1 1 Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *Correspondence to: Priyam Batra, Department

More information

Chapter 22. Pulmonary Infections

Chapter 22. Pulmonary Infections Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory

More information

Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa

Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa 973 Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa Jordi Rello, Paola Jubert, Jordi Valles, Antonio Artigas, Montse Rue, and Michael S. Niederman From the Department

More information

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results

More information

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality

PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and

More information

PULMONARY EMERGENCIES

PULMONARY EMERGENCIES EMERGENCIES I. Pneumonia A. Bacterial Pneumonia (most common cause of a focal infiltrate) 1. Epidemiology a. Accounts for up to 10% of hospital admissions in the U.S. b. Most pneumonias are the result

More information

Research & Reviews of. Pneumonia

Research & Reviews of. Pneumonia Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016

Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016 Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections

More information

Work-up of Respiratory Specimens Now you can breathe easier

Work-up of Respiratory Specimens Now you can breathe easier 34 th Annual Meeting Southwestern Association of Clinical Microbiology Work-up of Respiratory Specimens Now you can breathe easier Yvette S. McCarter, PhD, D(ABMM) Director, Clinical Microbiology Laboratory

More information

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results

More information

Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates

Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates (2010) 30, 270 274 r 2010 Nature Publishing Group All rights reserved. 0743-8346/10 $32 www.nature.com/jp ORIGINAL ARTICLE Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated

More information

Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D.

Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D. Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D. Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea

More information

Enterobacter aerogenes

Enterobacter aerogenes Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department

More information

THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA.

THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA. THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA. Dr. Poonam C. Sharma, Dr. S. S. Raut, Dr. S. R. More, Dr. V. S. Rathod, Dr. V. M. Gujar. 1. Post Graduate Student, Department of Microbiology,

More information

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES Upper Respiratory Tract Infections Return to Syllabus INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES General Goal: To know the major mechanisms of defense in the URT, the major mechanisms invaders use

More information

Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1

Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1 Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), 195-202 Investigation on hospital-acquired pneumonia and the association between hospital-acquired pneumonia and chronic comorbidity at the Department

More information

Babak Valizadeh, DCLS

Babak Valizadeh, DCLS Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological

More information

Community Acquired & Nosocomial Pneumonias

Community Acquired & Nosocomial Pneumonias Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP

More information

Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任

Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任 Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任 A Positive Blood Culture Clinically Important Organism Failure of host defenses to contain an infection at its primary focus Failure of the physician to effectively eradicate,

More information

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 320 MBIO Microbial Diagnosis Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 Blood Culture What is a blood culture? A blood culture is a laboratory test in which blood is injected into bottles with culture

More information

Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography

Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography CHEST 2014; 146(6): 1578-1585 文献精读 Diagnosis of Ventilator-Associated Pneumonia: A Pilot, Exploratory Analysis of a New Score Based on Procalcitonin and Chest Echography Giovanni Zagli, MD, PhD ; Morena

More information

Jean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert

Jean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert 538 Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen Brush Jean-Yves

More information

Guess or get it right?

Guess or get it right? Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders

More information

Original Article Characterization of candida species isolated from cases of lower respiratory tract infection

Original Article Characterization of candida species isolated from cases of lower respiratory tract infection Kathmandu University Medical Journal (2006), Vol. 4, No. 3, Issue 15, 290-294 Original Article Characterization of candida species isolated from cases of lower respiratory tract infection Jha BK 1, Dey

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for

More information

Research Article Eosinophil as a Protective Cell in S. aureus Ventilator-Associated Pneumonia

Research Article Eosinophil as a Protective Cell in S. aureus Ventilator-Associated Pneumonia Hindawi Publishing Corporation Mediators of Inflammation Volume 2013, Article ID 152943, 5 pages http://dx.doi.org/10.1155/2013/152943 Research Article Eosinophil as a Protective Cell in S. aureus Ventilator-Associated

More information

Thorax Online First, published on August 23, 2006 as /thx

Thorax Online First, published on August 23, 2006 as /thx Thorax Online First, published on August 23, 2006 as 10.1136/thx.2005.056374 Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

More information

Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period

Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period Original Article Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period Jiandong Mei 1, Lunxu Liu 1, Menglin Tang 2, Ninghui Xu 3,

More information

NOSOCOMIAL pneumonia (NP) is the second. Nosocomial Pneumonia in a Pediatric Intensive Care Unit

NOSOCOMIAL pneumonia (NP) is the second. Nosocomial Pneumonia in a Pediatric Intensive Care Unit Nosocomial Pneumonia in a Pediatric Intensive Care Unit P.K. Patra, M. Jayashree, S. Singhi, P. Ray* and A.K. Saxena** From the Departments of Pediatrics, Microbiology* and Radiodiagnosis** Postgraduate

More information

Aerobic bacteria isolated from diabetic septic wounds

Aerobic bacteria isolated from diabetic septic wounds Aerobic bacteria isolated from diabetic septic wounds Eithar Mohammed Mahgoub*, Mohammed Elfatih A. Omer Faculty of Pharmacy, Omdurman Islamic University Department of Pharmaceutical Microbiology, Omdurman

More information

Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease

Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease 29 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Bronchoscopic validation of the significance of purulence in severe exacerbations of chronic obstructive pulmonary disease Néstor Soler, Carlos Agustí, Joaquim

More information

Ventilator-associated pneumonia

Ventilator-associated pneumonia Respirology (2009) 14 (Suppl. 2) S51 S58 doi: 10.1111/j.1400-1843.2009.01577.x CHAPTER VIII Ventilator-associated pneumonia SUMMARY Ventilator-associated pneumonia is a pneumonia that develops initially

More information

A study on common pathogens associated with nosocomial infections and their antibiotic sensitivity

A study on common pathogens associated with nosocomial infections and their antibiotic sensitivity International Journal of Contemporary Pediatrics Ahirrao VS et al. Int J Contemp Pediatr. 2017 Mar;4(2):365-369 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:

More information

Ventilator Associated

Ventilator Associated Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,

More information

Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures

Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02649.x Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures B. Herer 1,2, C. Fuhrman 2, Z. Gazevic

More information

Bacteriological Profile of Post Traumatic Osteomyelitis in a Tertiary Care Centre

Bacteriological Profile of Post Traumatic Osteomyelitis in a Tertiary Care Centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 367-372 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.044

More information

COPD guidelines in relation to infections: a critical analysis

COPD guidelines in relation to infections: a critical analysis All course materials, including the original lecture, are available as webcasts/podcasts at www.ers-educationorg pages/default. aspx?id=1339&idbrowse=47399 COPD guidelines in relation to infections: a

More information

Prevalence of Streptococcus pneumoniae in Respiratory Samples 1. from Patients with Tracheostomy in a Long-Term Care Facility 2

Prevalence of Streptococcus pneumoniae in Respiratory Samples 1. from Patients with Tracheostomy in a Long-Term Care Facility 2 JCM Accepts, published online ahead of print on 25 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.00763-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Prevalence of Streptococcus

More information

BIP Endotracheal Tube

BIP Endotracheal Tube Bactiguard Infection Protection BIP Endotracheal Tube For prevention of healthcare associated infections Ventilator associated pneumonia Infections of the respiratory tract are serious and common healthcare

More information

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis Journal of Medical Microbiology (2004), 53, 879 885 DOI 10.1099/jmm.0.45655-0 Short Communication Correspondence Itzhak Brook ib6@georgetown.edu Received 1 March 2004 Accepted 18 May 2004 Discrepancies

More information

Microbial Flora of Normal Human Body Dr. Kaya Süer. Near East University Medical Faculty Infectious Diseases and Clinical Microbiology

Microbial Flora of Normal Human Body Dr. Kaya Süer. Near East University Medical Faculty Infectious Diseases and Clinical Microbiology Microbial Flora of Normal Human Body Dr. Kaya Süer Near East University Medical Faculty Infectious Diseases and Clinical Microbiology Normal Microbial Flora Skin Conjunctivae Oral Cavity Upper respiratory

More information

Acceptability of Sputum Specimens

Acceptability of Sputum Specimens JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1982, p. 627-631 0095-1137/82/100627-05$02.00/0 Copyright C 1982, American Society for Microbiology Vol. 16, No. 4 Comparison of Six Different Criteria for Judging

More information

Lecture Notes. Chapter 16: Bacterial Pneumonia

Lecture Notes. Chapter 16: Bacterial Pneumonia Lecture Notes Chapter 16: Bacterial Pneumonia Objectives Explain the epidemiology Identify the common causes Explain the pathological changes in the lung Identify clinical features Explain the treatment

More information

ABSTRACT PURPOSE METHODS

ABSTRACT PURPOSE METHODS ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection

More information

Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns

Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns The Turkish Journal of Pediatrics 2006; 48: 213-220 Original Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns Nilgün Köksal 1, Mustafa Hacımustafaoğlu

More information

Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy.

Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Written by: Dr K Gajee, Consultant Microbiologist Date: June 2017 Approved by: Drugs & Therapeutics Committee

More information

ORIGINAL INVESTIGATION. Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa

ORIGINAL INVESTIGATION. Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa Incidence, Risk, and Prognosis ORIGINAL INVESTIGATION Francisco Arancibia, MD; Torsten T. Bauer, MD; Santiago Ewig,

More information

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1 Lab 4. Blood Culture (Media) 2018 320 MIC AMAL-NORA-ALJAWHARA 1 Blood Culture 2018 320 MIC AMAL-NORA-ALJAWHARA 2 What is a blood culture? A blood culture is a laboratory test in which blood is injected

More information

F. Burgos*, A. Torres*, J. González**, J. Puig de la Bellacasa**, R. Rodriguez-Roisin*, J. Roca*

F. Burgos*, A. Torres*, J. González**, J. Puig de la Bellacasa**, R. Rodriguez-Roisin*, J. Roca* Eur Respir J, 1996, 9, 2612 2617 DOI: 10.1183/09031936.96.09122612 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Bacterial colonization

More information

Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia

Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia ACTA BIOMED 2008; 79: 117-122 Mattioli 1885 O R I G I N A L A R T I C L E Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia Haleh

More information

Impact of humidification and gas warming systems on ventilatorassociated

Impact of humidification and gas warming systems on ventilatorassociated Online Data Supplement Impact of humidification and gas warming systems on ventilatorassociated pneumonia. Jean-Claude Lacherade, M.D. 1, Marc Auburtin, M.D. 2, Charles Cerf, M.D. 3, Andry Van de Louw,

More information

MUSTAFA EL-EBIARY, ANTONI TORRES, NEUS FÀBREGAS, JORGE PUIG

MUSTAFA EL-EBIARY, ANTONI TORRES, NEUS FÀBREGAS, JORGE PUIG Significance of the Isolation of Candida Species from Respiratory Samples in Critically Ill, Non-neutropenic Patients An Immediate Postmortem Histologic Study MUSTAFA EL-EBIARY, ANTONI TORRES, NEUS FÀBREGAS,

More information

Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit

Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit Thorax 1998;53:1053 1058 1053 Internal Medicine, University Hospital Maastricht, Maastricht, The DCJJBergmans S van der Geest R M Wilting P W de Leeuw Internal Medicine, University Hospital Utrecht, Utrecht,

More information

The characteristics of bacterial pathogens in cases of children with respiratory tract infection in Eastern area.

The characteristics of bacterial pathogens in cases of children with respiratory tract infection in Eastern area. Biomedical Research 2018; 29 (5): 1008-1013 ISSN 0970-938X www.biomedres.info The characteristics of bacterial pathogens in 15000 cases of children with respiratory tract infection in Eastern area. Guiting

More information

RHODOCOCCUS EQUI. Post-mortem Environmental Persistence Specific Control Measures Release of Animals from Isolation

RHODOCOCCUS EQUI. Post-mortem Environmental Persistence Specific Control Measures Release of Animals from Isolation RHODOCOCCUS EQUI Definition Clinical Signs Transmission Diagnostic Sampling, Testing and Handling Post-mortem Environmental Persistence Specific Control Measures Release of Animals from Isolation Biosecurity

More information

From the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital

From the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures

More information

Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia

Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia Eur Respir J, 99, 9, 79 7 DOI: 0.8/0909.9.090879 Printed in UK - all rights reserved Copyright ERS Journals Ltd 99 European Respiratory Journal ISSN 090-9 SERIES 'CLINICAL PHYSIOLOGY IN RESPIRATORY INTENSIVE

More information

ORIGINAL INVESTIGATION. Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease

ORIGINAL INVESTIGATION. Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease ORIGINAL INVESTIGATION Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease Antoni Rosell, MD; Eduard Monsó, MD; Néstor Soler, MD; Ferràn Torres, MD; Joaquim Angrill, MD;

More information

Jean Chastre, Jean-Louis Trouillet, Alain Combes, and Charles-Edouard Luyt

Jean Chastre, Jean-Louis Trouillet, Alain Combes, and Charles-Edouard Luyt SUPPLEMENT ARTICLE Diagnostic Techniques and Procedures for Establishing the Microbial Etiology of Ventilator- Associated Pneumonia for Clinical Trials: The Pros for Quantitative Cultures Jean Chastre,

More information

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: July 2013 Approved by: The Drugs & Therapeutics Committee Date: April 2016 Implementation

More information

Aerosolized Antibiotics in Mechanically Ventilated Patients

Aerosolized Antibiotics in Mechanically Ventilated Patients Aerosolized Antibiotics in Mechanically Ventilated Patients Gerald C Smaldone MD PhD Introduction Topical Delivery of Antibiotics to the Lung Tracheobronchitis Aerosolized Antibiotic Delivery in the Medical

More information

Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease

Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease Skin reactivity to autologous bacteria 149 Original Article Skin reactivity to autologous bacteria isolated from respiratory tract of patients with obstructive pulmonary disease J. Halasa 1, M. Halasa

More information

Key words: antimicrobial treatment; diagnosis; Gram stain; outcome; pneumonia; sputum

Key words: antimicrobial treatment; diagnosis; Gram stain; outcome; pneumonia; sputum Applying Sputum as a Diagnostic Tool in Pneumonia* Limited Yield, Minimal Impact on Treatment Decisions Santiago Ewig, MD; Matthias Schlochtermeier, MD; Norbert Göke, MD; Michael S. Niederman, MD, FCCP

More information

Predictors and Outcome of Early-Onset Pneumonia After Out-of-Hospital Cardiac Arrest

Predictors and Outcome of Early-Onset Pneumonia After Out-of-Hospital Cardiac Arrest Predictors and Outcome of Early-Onset Pneumonia After Out-of-Hospital Cardiac Arrest Dirk Pabst MD, Sonja Römer MD, Alexander Samol MD, Philipp Kümpers MD, Johannes Waltenberger MD, and Pia Lebiedz MD

More information

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

PNEUMONIA IN CHILDREN. IAP UG Teaching slides PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children

More information

Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease

Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease Sanjay Sethi 1,2, Rohin Sethi 2, Karen Eschberger 2, Phyllis Lobbins 3, Xueya Cai 4, Brydon J. B. Grant 1,2, and

More information

All previously published papers and figures were reproduced with permission from the publisher.

All previously published papers and figures were reproduced with permission from the publisher. All previously published papers and figures were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB. Petra Hyllienmark, 2013 ISBN ISBN

More information

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods

Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services

More information

PERCUTANEOUS DILATATIONAL TRACHEOSTOMY

PERCUTANEOUS DILATATIONAL TRACHEOSTOMY PERCUTANEOUS DILATATIONAL TRACHEOSTOMY GM KOKSAL *, NC SAYILGAN * AND H OZ ** Abstract Background: The aim of this study was to investigate the rate, timing, the incidence of complications of percutaneous

More information

American College of Surgeons Critical Care Review Course 2012: Infection Control

American College of Surgeons Critical Care Review Course 2012: Infection Control American College of Surgeons Critical Care Review Course 2012: Infection Control Overview: I. Central line associated blood stream infection (CLABSI) II. Ventilator associated pneumonia (VAP) I. Central

More information

POLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS

POLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS POLICY F TREATMENT OF LOWER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: The Drugs & Therapeutics Committee Date: July 2018 Implementation

More information

by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis

by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis Steroids in acute bacterial meningitis Javier Garau, MD, PhD University of Barcelona Spain ESCMID Summer School, Porto, July 2009 Dexamethasone treatment in childhood bacterial meningitis in Malawi: a

More information

Bacteraemia in patients receiving human cadaveric

Bacteraemia in patients receiving human cadaveric J. clin. Path., 1971, 24, 295-299 Bacteraemia in patients receiving human cadaveric renal transplants D. A. LEIGH1 From the Department of Bacteriology, The Wright-Fleming Institute, St Mary's Hospital,

More information

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

POLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: Date: July 2018 The Drugs & Therapeutics Committee Implementation

More information